153 related articles for article (PubMed ID: 23707465)
1. Association between a polymorphism in cannabinoid receptor 2 and severe necroinflammation in patients with chronic hepatitis C.
Coppola N; Zampino R; Bellini G; Macera M; Marrone A; Pisaturo M; Boemio A; Nobili B; Pasquale G; Maione S; Adinolfi LE; Perrone L; Sagnelli E; Miraglia Del Giudice E; Rossi F
Clin Gastroenterol Hepatol; 2014 Feb; 12(2):334-40. PubMed ID: 23707465
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients.
Sagnelli C; Uberti-Foppa C; Hasson H; Bellini G; Minichini C; Salpietro S; Messina E; Barbanotti D; Merli M; Punzo F; Coppola N; Lazzarin A; Sagnelli E; Rossi F
PLoS One; 2017; 12(7):e0181890. PubMed ID: 28759568
[TBL] [Abstract][Full Text] [Related]
3. In vivo evidence that the cannabinoid receptor 2-63 RR variant is associated with the acquisition and/or expansion of HIV infection.
Sagnelli C; Uberti-Foppa C; Hasson H; Bellini G; Minichini C; Salpietro S; Messina E; Barbanotti D; Merli M; Punzo F; Coppola N; Lazzarin A; Sagnelli E; Rossi F
HIV Med; 2018 Oct; 19(9):597-604. PubMed ID: 29932291
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C.
Coppola N; Zampino R; Sagnelli C; Bellini G; Marrone A; Stanzione M; Capoluongo N; Boemio A; Minichini C; Adinolfi LE; Maione S; Del Giudice EM; Sagnelli E; Rossi F
PLoS One; 2014; 9(6):e99450. PubMed ID: 24940753
[TBL] [Abstract][Full Text] [Related]
5. The impact of the CB2-63 polymorphism on the histological presentation of chronic hepatitis B.
Coppola N; Zampino R; Bellini G; Stanzione M; Capoluongo N; Marrone A; Macera M; Pasquale G; Boemio A; Maione S; Adinolfi LE; Del Giudice EM; Sagnelli E; Rossi F
Clin Microbiol Infect; 2015 Jun; 21(6):609.e1-4. PubMed ID: 25749560
[TBL] [Abstract][Full Text] [Related]
6. CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection.
Coppola N; Zampino R; Bellini G; Stanzione M; Capoluongo N; Marrone A; Macera M; Adinolfi LE; Giudice EM; Gentile I; Sagnelli E; Rossi F
Dig Liver Dis; 2016 Nov; 48(11):1364-1369. PubMed ID: 27476469
[TBL] [Abstract][Full Text] [Related]
7. Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C.
Flores-Contreras L; Sandoval-Rodríguez AS; Mena-Enriquez MG; Lucano-Landeros S; Arellano-Olivera I; Alvarez-Álvarez A; Sanchez-Parada MG; Armendáriz-Borunda J
BMC Gastroenterol; 2014 Jul; 14():131. PubMed ID: 25064094
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
[TBL] [Abstract][Full Text] [Related]
9. The cannabinoid receptor type 2 Q63R variant increases the risk of celiac disease: implication for a novel molecular biomarker and future therapeutic intervention.
Rossi F; Bellini G; Tolone C; Luongo L; Mancusi S; Papparella A; Sturgeon C; Fasano A; Nobili B; Perrone L; Maione S; del Giudice EM
Pharmacol Res; 2012 Jul; 66(1):88-94. PubMed ID: 22465144
[TBL] [Abstract][Full Text] [Related]
10. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid CB2 receptor gene (CNR2) polymorphism is associated with chronic childhood immune thrombocytopenia in Egypt.
Mahmoud Gouda H; Mohamed Kamel NR
Blood Coagul Fibrinolysis; 2013 Apr; 24(3):247-51. PubMed ID: 23406660
[TBL] [Abstract][Full Text] [Related]
12. Impact of amino acid substitutions in the hepatitis C virus genotype 1b core region on liver steatosis and hepatic oxidative stress in patients with chronic hepatitis C.
Tachi Y; Katano Y; Honda T; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Samejima Y; Goto H
Liver Int; 2010 Apr; 30(4):554-9. PubMed ID: 19951380
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
[TBL] [Abstract][Full Text] [Related]
14. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.
Adinolfi LE; Gambardella M; Andreana A; Tripodi MF; Utili R; Ruggiero G
Hepatology; 2001 Jun; 33(6):1358-64. PubMed ID: 11391523
[TBL] [Abstract][Full Text] [Related]
15. Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients.
Adinolfi LE; Ingrosso D; Cesaro G; Cimmino A; D'Antò M; Capasso R; Zappia V; Ruggiero G
Hepatology; 2005 May; 41(5):995-1003. PubMed ID: 15834927
[TBL] [Abstract][Full Text] [Related]
16. The Cannabinoid Receptor 2 Q63R Variant Modulates the Relationship between Childhood Obesity and Age at Menarche.
Bellini G; Grandone A; Torella M; Miraglia del Giudice E; Nobili B; Perrone L; Maione S; Rossi F
PLoS One; 2015; 10(10):e0140142. PubMed ID: 26447698
[TBL] [Abstract][Full Text] [Related]
17. Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation.
Sterling RK; Sanyal AJ; Luketic VA; Stravitz RT; King AL; Post AB; Mills AS; Contos MJ; Shiffman ML
Am J Gastroenterol; 1999 Dec; 94(12):3576-82. PubMed ID: 10606322
[TBL] [Abstract][Full Text] [Related]
18. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
[TBL] [Abstract][Full Text] [Related]
19. Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection.
Bihrer V; Friedrich-Rust M; Kronenberger B; Forestier N; Haupenthal J; Shi Y; Peveling-Oberhag J; Radeke HH; Sarrazin C; Herrmann E; Zeuzem S; Waidmann O; Piiper A
Am J Gastroenterol; 2011 Sep; 106(9):1663-9. PubMed ID: 21606975
[TBL] [Abstract][Full Text] [Related]
20. Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts.
Trebicka J; Racz I; Siegmund SV; Cara E; Granzow M; Schierwagen R; Klein S; Wojtalla A; Hennenberg M; Huss S; Fischer HP; Heller J; Zimmer A; Sauerbruch T
Liver Int; 2011 Jul; 31(6):860-70. PubMed ID: 21645218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
